With the increasing number of cell and gene therapy (CGT) products in clinical development, Cencora?s FormularyDecisions launched a new resource designed to provide healthcare payers with centralized access to information on approved therapies and products in the pipeline. A secure online platform, FormularyDecisions provides healthcare decision-makers in the United States with access to evidence-based resources and facilitates information exchange between biopharma companies and payers. Through this CGT resource, registered healthcare payers ?

which collectively represent more than 269 million covered lives ? will have access to a detailed overview of the CGT landscape and product-based information, such as clinical evidence and health economic information, launch status and designations awarded by the U.S. Food and Drug Administration (FDA). Cencora, which offers CGT developers support at every stage of the product lifecycle, also recently launched a CGT Integration Hub, which connects provider-facing platforms with patient services support programs to increase visibility across the therapy development and delivery process, streamlining the path-to-care.